David Klatzmann

David Klatzmann received his M.D. and Ph.D. from the Pierre and Marie Curie Medical School, Paris, France. He is Professor of Immunology and Head of the Inflammation-Immunopathology-Biotherapy Department at the Pierre and Marie Curie Medical School. His main research interests are translational immunology and immunotherapy, with a special focus on regulatory T cells. He and his group pioneered the use of low-dose interleukin-2 immunotherapies. David Klatzmann's homepage .